Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04049695 · ClinicalTrials.gov registry record · NA
Improving Cognition After Cancer
A NA study of Cognitive Dysfunction and Breast Cancer Survivors, sponsored by University of California, San Diego.
- Active
- Registry status
- NA
- Development phase
- 253
- Enrollment target
- 1
- Study location
NCT04049695: Active NA study of Cognitive Dysfunction and Breast Cancer Survivors, sponsored by University of California, San Diego.
NCT04049695 is a NA study of Cognitive Dysfunction and Breast Cancer Survivors that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 253 participants, below the 1,987-participant average among 45 other Cognitive Dysfunction trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04049695, a NA study of Cognitive Dysfunction and Breast Cancer Survivors, is active but no longer recruiting, sponsored by University of California, San Diego.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 253 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test whether a physical activity intervention can improve cognition in breast cancer survivors and help the development of physical activity guidelines for cognition in breast cancer survivors.
Conditions Studied
Interventions
- BEHAVIORAL Exercise
- BEHAVIORAL Control
Study Locations (1)
California
- Moores UCSD Cancer Center - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2019-09-09 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
What the registry record for NCT04049695 still lists
NCT04049695 is an interventional study that assigns participants to a tested intervention. The registered 253 participants enrollment target is mid-sized for trials with a published cap, below the 1,987-participant average among 45 other Cognitive Dysfunction trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Cognitive Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.
NCT04049695 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04049695 about?
NCT04049695 is a clinical study titled "Improving Cognition After Cancer". This study will test whether a physical activity intervention can improve cognition in breast cancer survivors and help the development of physical activity guidelines for cognition in breast cancer survivors.
What is the current status of trial NCT04049695?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 253 participants. The study started on 2019-09-09. Estimated completion is 2025-02-01.
What conditions does trial NCT04049695 study?
This clinical trial studies the following conditions: Cognitive Dysfunction, Breast Cancer Survivors.
What interventions are being tested in trial NCT04049695?
The interventions under investigation include: Exercise (BEHAVIORAL), Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT04049695?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04049695 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04049695's enrollment target sits among peer trials
253 13th of 45 higher than 33 of 45 other Cognitive Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Deficits
RECRUITING · NA
-
Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment
RECRUITING · NA
-
High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV
RECRUITING · NA
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
-
Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
RECRUITING · NA
-
Strengthening Neuro-Cognitive Skills for Success in School, Work and Beyond
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI